QT IMAGING HOLDINGS, INC.QTIEarnings & Financial Report
QT Imaging Holdings, Inc. is a medical technology company that designs, manufactures and commercializes non-invasive medical imaging systems primarily for breast health diagnostics. It serves healthcare providers, clinics and medical institutions across key markets including North America, Europe and Asia-Pacific, focusing on improving the accuracy and accessibility of diagnostic imaging for patients.
Revenue
$1.7M
Gross Profit
$874.6K
Operating Profit
$-2.2M
Net Profit
$-1.2M
Gross Margin
51.0%
Operating Margin
-129.5%
Net Margin
-72.9%
YoY Growth
53749.7%
EPS
$-0.30
QT IMAGING HOLDINGS, INC. Q2 FY2024 Financial Summary
QT IMAGING HOLDINGS, INC. reported revenue of $1.7M (up 53749.7% YoY) for Q2 FY2024, with a net profit of $-1.2M (up 6.1% YoY) (-72.9% margin). Cost of goods sold was $839.5K, operating expenses totaled $3.1M.
Key Financial Metrics
| Total Revenue | $1.7M |
|---|---|
| Net Profit | $-1.2M |
| Gross Margin | 51.0% |
| Operating Margin | -129.5% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
QT IMAGING HOLDINGS, INC. Q2 FY2024 revenue of $1.7M breaks down across 2 segments, led by Products at $1.7M (96.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $1.7M | 96.8% |
| Other | $55.4K | 3.2% |
QT IMAGING HOLDINGS, INC. Annual Revenue by Year
QT IMAGING HOLDINGS, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $18.9M).
| Year | Annual Revenue |
|---|---|
| 2025 | $18.9M |
QT IMAGING HOLDINGS, INC. Quarterly Revenue & Net Profit History
QT IMAGING HOLDINGS, INC. results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $8.3M | +877.2% | $-1.4M | -16.8% |
| Q3 FY2025 | $4.2M | +338.5% | $-4.6M | -108.7% |
| Q2 FY2025 | $3.7M | +113.5% | $-4.0M | -109.3% |
| Q1 FY2025 | $2.8M | +105.4% | $-11.1M | -397.9% |
| Q2 FY2024 | $1.7M | +53749.7% | $-1.2M | -72.9% |
| Q1 FY2024 | $1.4M | +17908.5% | $-628.6K | -46.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4M | $1.7M | $2.8M | $3.7M | $4.2M | $8.3M |
| YoY Growth | 17908.5% | 53749.7% | 105.4% | 113.5% | 338.5% | 877.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|
| Assets | $12.9M | $10.8M | $10.9M | $11.6M | $12.1M | $23.0M |
| Liabilities | $17.8M | $16.9M | $31.1M | $12.0M | $21.2M | $16.6M |
| Equity | $-4.9M | $-6.2M | $-20.2M | $-324294 | $-9.1M | $6.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-6.0M | $-979566 | $-3.5M | $-1.4M | $-878750 | $-3.1M |